- The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia2022 | First Faculty of Medicine
- An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus2022 | First Faculty of Medicine
- Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes2020 | First Faculty of Medicine
- Cost-Effectiveness of IDegLira Versus Insulin Intensification Regimens for the Treatment of Adults with Type 2 Diabetes in the Czech Republic2017 | Second Faculty of Medicine
- Dulaglutid2016 | Second Faculty of Medicine
- Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results2022 | First Faculty of Medicine